Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (2616)	3/3/1998 8:18:00 AM
From: Linda Kaplan	Respond to of 7041

Gosh. I'm speechless. Linda

To: Arthur Radley who wrote (2616)	3/3/1998 9:20:00 AM
From: Brander	Respond to of 7041

Good point Texas Dude; it is true that major pharmaceuticals often make long shot investments in developmental biotech companies just in case their drug works out. This is very common and necessary because of the intense competition in the pharmaceutical industry. Brad

To: Arthur Radley who wrote (2616)	3/3/1998 12:58:00 PM
From: clochard	Read Replies (1) \| Respond to of 7041

"they are dropping their alliance because the AMLN drug DOESN'T work. A $160 million dollar mistake by a major drug company. " And when one of those companies realize that ZONA was a mistake they will sell their little bundle of stocks, pushing the price off a cliff, just like AMLN. Until then, the price will probably stay around $18 because there are enough baby blue eyed suckers around to keep it afloat. Reminds me of "Law and Order" where there are multiple suspects and each one is told that whoever squeals first gets a deal and the rest (literally) get the shaft!